These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies. Mazzulli JR; Xu YH; Sun Y; Knight AL; McLean PJ; Caldwell GA; Sidransky E; Grabowski GA; Krainc D Cell; 2011 Jul; 146(1):37-52. PubMed ID: 21700325 [TBL] [Abstract][Full Text] [Related]
10. Depth of α-synuclein in a bilayer determined by fluorescence, neutron reflectometry, and computation. Pfefferkorn CM; Heinrich F; Sodt AJ; Maltsev AS; Pastor RW; Lee JC Biophys J; 2012 Feb; 102(3):613-21. PubMed ID: 22325285 [TBL] [Abstract][Full Text] [Related]
11. Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains. Gegg ME; Burke D; Heales SJ; Cooper JM; Hardy J; Wood NW; Schapira AH Ann Neurol; 2012 Sep; 72(3):455-63. PubMed ID: 23034917 [TBL] [Abstract][Full Text] [Related]
13. Loss of β-glucocerebrosidase activity does not affect alpha-synuclein levels or lysosomal function in neuronal cells. Dermentzaki G; Dimitriou E; Xilouri M; Michelakakis H; Stefanis L PLoS One; 2013; 8(4):e60674. PubMed ID: 23580063 [TBL] [Abstract][Full Text] [Related]
14. The effect of mutant GBA1 on accumulation and aggregation of α-synuclein. Maor G; Rapaport D; Horowitz M Hum Mol Genet; 2019 Jun; 28(11):1768-1781. PubMed ID: 30615125 [TBL] [Abstract][Full Text] [Related]
15. Involvement of Gaucher Disease Mutations in Parkinson Disease. Vilageliu L; Grinberg D Curr Protein Pept Sci; 2017; 18(7):758-764. PubMed ID: 26965692 [TBL] [Abstract][Full Text] [Related]